Carfilzomib-based induction improves progression free survival and rate of minimal residual disease negativity following autologous transplant in high risk multiple myeloma patients: a retrospective analysis
Parrondo, Ricardo, Biran, Noa, Roy, Vivek, Bodepudi, Sri Lekha, Shareef, Zan, Ailawadhi, SikanderVolume:
19
Journal:
Clinical Lymphoma Myeloma and Leukemia
DOI:
10.1016/j.clml.2019.09.361
Date:
October, 2019
File:
PDF, 60 KB
2019